当前位置:首页 - 行情中心 - 星昊医药(920017) - 财务分析 - 现金流量表

星昊医药

(920017)

  

流通市值:22.44亿  总市值:22.68亿
流通股本:1.23亿   总股本:1.24亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金341,910,895.21169,972,181.86668,879,414.12504,051,042.5
  收到的税费返还-02,076,270.252,076,270.25
  收到其他与经营活动有关的现金28,044,096.5320,793,160.8860,405,434.0834,541,346.38
  经营活动现金流入小计369,954,991.74190,765,342.74731,361,118.45540,668,659.13
  购买商品、接受劳务支付的现金61,573,185.8326,973,251.94116,784,764.12120,148,057.4
  支付给职工以及为职工支付的现金45,651,833.5122,409,427.3394,712,549.7872,328,486.26
  支付的各项税费42,743,368.7719,402,213.4363,502,586.3748,672,396.27
  支付其他与经营活动有关的现金107,782,299.5549,620,054.87282,137,211.56215,339,660.64
  经营活动现金流出小计257,750,687.66118,404,947.57557,137,111.83456,488,600.57
  经营活动产生的现金流量净额112,204,304.0872,360,395.17174,224,006.6284,180,058.56
二、投资活动产生的现金流量:
  收回投资收到的现金493,252,246.49335,252,246.49909,000,000732,030,000
  取得投资收益收到的现金5,253,775.023,885,579.126,630,042.475,713,573.97
  处置固定资产、无形资产和其他长期资产收回的现金净额--4,0004,000
  收到的其他与投资活动有关的现金11,622,163.44-16,060,190.0516,060,190.05
  投资活动现金流入小计510,128,184.95339,137,825.61931,694,232.52753,807,764.02
  购建固定资产、无形资产和其他长期资产支付的现金47,929,679.3333,867,523.66113,628,725.9140,520,134.34
  投资支付的现金604,000,000418,000,000980,000,000755,000,000
  支付其他与投资活动有关的现金2,353,625.45-11,622,163.44-
  投资活动现金流出小计654,283,304.78451,867,523.661,105,250,889.35795,520,134.34
  投资活动产生的现金流量净额-144,155,119.83-112,729,698.05-173,556,656.83-41,712,370.32
三、筹资活动产生的现金流量:
  吸收投资收到的现金--33,118,47033,118,470
  收到其他与筹资活动有关的现金10,571,006.94-6,403,870.78-
  筹资活动现金流入小计10,571,006.94039,522,340.7833,118,470
  分配股利、利润或偿付利息支付的现金74,461,749.358,75019,676,513.819,617,111.03
  支付其他与筹资活动有关的现金5,640,000-823,798.8-
  筹资活动现金流出小计80,101,749.358,75020,500,312.619,617,111.03
  筹资活动产生的现金流量净额-69,530,742.36-58,75019,022,028.1813,501,358.97
四、汇率变动对现金及现金等价物的影响-795,614.18-524,448.8964,379.321,100,650.57
五、现金及现金等价物净增加额-102,277,172.29-40,952,501.6820,653,757.2957,069,697.78
  加:期初现金及现金等价物余额434,583,244.68446,205,408.12413,929,487.39413,929,487.39
  期末现金及现金等价物余额332,306,072.39405,252,906.44434,583,244.68470,999,185.17
补充资料:
  净利润53,240,074.09-103,044,799.11-
  资产减值准备2,728,950.96-6,368,590.38-
  固定资产和投资性房地产折旧24,529,316.1-47,922,830.77-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧24,529,316.1-47,922,830.77-
  无形资产摊销1,965,819.08-4,244,937.55-
  长期待摊费用摊销--68,807.34-
  处置固定资产、无形资产和其他长期资产的损失--36.47-
  固定资产报废损失--348.31-
  公允价值变动损失-3,481,390.42--3,538,306.82-
  财务费用-1,344,763.21--2,942,555.57-
  投资损失-1,819,917.16--3,802,693.03-
  递延所得税-2,202,621.8-2,938,468.95-
  其中:递延所得税资产减少-2,199,234.39-2,452,717.52-
    递延所得税负债增加-3,387.41-485,751.43-
  存货的减少-6,513,606.75--8,392,295.7-
  经营性应收项目的减少17,140,995.1-5,915,323.94-
  经营性应付项目的增加28,534,178.39-10,457,875.5-
  现金的期末余额332,306,072.39-434,583,244.68-
  减:现金的期初余额434,583,244.68-413,929,487.39-
  现金及现金等价物的净增加额-102,277,172.29-20,653,757.29-
公告日期2026-08-102026-04-292026-04-242025-10-28
审计意见(境内)标准无保留意见
TOP↑